Skip to content

We discover biomarkers and design companion diagnostics for immuno-oncology and cell therapies

We unlock the full potential of single-cell omics and unravel the complexity of cancer diseases

USZ Zurich
Inselspital
Geninus logo

The problem we are solving:

Precision biomarkers & companion diagnostics

Most drugs work only on a fraction of the patients, leading to high failure rates of clinical trials and poor efficacy of drugs when delivered to patients. This calls for precision medicine solutions that match the right patient to the right treatment. Combining deep molecular profiling and our unbiased and robust AI discovery platform ScaiVision leads to highly accurate biomarkers and clinically-relevant insights.

clinical trials

90% of clinical trials fail

50% of failed trials lack clinical efficacy

90 / 50

Actionable biomarkers

approved drugs

90% of approved drugs work only in

50% of the patients

What biomarkers are you looking for?

We discover clinically-relevant biomarkers with single-cell analytics and AI

Disease diagnosis​

Disease diagnosis

Identify novel biomarkers for an early disease diagnosis

Patient stratification​

Patient stratification

Identify patients with higher chance to respond to treatment

Mode of Action​

Mode of
Action

Understand the effect on patient’s immune response

Patient monitoring​

Patient monitoring

Identify prognostic and predictive biomarkers

12 successful discovery projects

1000+ single cell samples analyzed

50 Billion data points

We revolutionize biomarker discovery with AI and single-cell data

Single-cell resolution icon

Single-cell resolution

We harness the richness of single-cell multiomics data to explain complex biological processes

Artificial Intelligence Icon

Artificial Intelligence

We apply AI for unbiased, innovative, sensitive, and integrative multiomics data analysis

Biomarker discovery icon

Biomarker discovery

We deliver translatable biomarker signatures related to therapy response, diagnosis or disease severity

Gain superior speed, robustness, translatability, and unmatched discovery potential

Play Video about Scailyte's Strengths
Gain superior speed, robustness, translatability and unmatched discovery potential

Faster time-to-insights for accelerated biomarker discovery

Sensitive and specific biomarker discovery to identify clinical biomarkers not achievable by conventional analytics

Fully transparent and explainable results allow the translation of biomarker discoveries into simple, affordable clinical assays

Demonstrated best-in-class AI, ensuring superior robustness and reliability of biomarker discoveries

The discovery and development of biomarkers for precision medicine using single-cell data and AI fully exploits the power of cutting-edge technologies in translational research. We are paving the way for the development of new life-saving diagnostics and next-generation therapeutics for complex diseases.

Learn about our solutions for drug developers
Hemex

Partner Testimonials

Meghan Verschoor

Meghan Verschoor

Associate Director, Data Science in Clinical and Translational Medicine at Turnstone Biologics

“Our team is very impressed with the level of attention to detail and domain knowledge that the Scailyte team brings to our project. We’re excited to continue working with your team!”
Thomas Mehrling

Thomas Mehrling

MD PhD, CEO of MaxiVAX

“Scailyte has been instrumental in analyzing phase IIa clinical single-arm trial data of our most advanced development program. Scailyte’s scientific expertise, communication style and agility are commendable”
Prof. Dr Michael Mueller

Prof. Dr Michael Mueller

Leading Clinician in Women’s Health & Scientific Advisor

“Our current collaboration with Scailyte in the field of women’s health is a truly innovative approach. We are integrating cutting edge technologies to develop biomarkers that will be the basis for impactful diagnostic solutions.”
Pascal Koenig

Pascal Koenig

Entrepreneur & Chairman of the Board of Directors

“As the co-founder and former CEO of Ava Women, I have experienced the power that big datasets have on the healthcare industry. Scailyte’s mission, proven technology and strong expertise have convinced me to join the team. I am delighted to contribute and assist in bringing Scailyte’s solution to patients around the world.”

Recent News

Inside Scailyte – Episode 6: Meet Julian Spagnuolo

In this episode, Julian shares his insights into the intersection of data science and immunology, hi...

Read more

Recent News

Meet Scailyte at Immuno-Oncology 360° in New York, USA

Our very own Diana Stoycheva and Peter Nestorov will be representing Scailyte at the conference at b...

Read more

Recent News

Inside Scailyte – Episode 5: Meet Daniel Schoener

Join us as we introduce you to Daniel Schoener, Executive Business Advisor at Scailyte AG. Daniel's ...

Read more

Recent News

ScaiDigest Volume 7: Unveiling Insights into Autoimmune Diseases

We're thrilled to share the latest installment of our ScaiDigest series, authored by our very own Di...

Read more

Recent News

Inside Scailyte – Episode 4: Meet Peter Evans

In this special episode, we introduce you to Peter Evans, our Principal IT Engineer at Scailyte AG. ...

Read more

Recent News

Inside Scailyte – Episode 3: Meet Peter Nestorov

Join us as Peter Nestorov, the Founder and CEO of Scailyte shares the pivotal role of Scailyte in th...

Read more

Recent News

Festival of Genomics 2024

Scailyte will be a part of the upcoming Festival of Genomics, on January 24th and 25th, 2024, in Lon...

Read more

Recent News

Inside Scailyte - Episode 2: Filipa Teixeira

We're back with another exciting episode of "Inside Scailyte," where we delve into the incredible jo...

Read more

Recent News

01 /04

Inside Scailyte – Episode 6: Meet Julian Spagnuolo

In this episode, Julian shares his insights into the intersection of data science and immunology, hi...

Read more

Meet Scailyte at Immuno-Oncology 360° in New York, USA

Our very own Diana Stoycheva and Peter Nestorov will be representing Scailyte at the conference at b...

Read more

Recent News

02 /04

Inside Scailyte – Episode 5: Meet Daniel Schoener

Join us as we introduce you to Daniel Schoener, Executive Business Advisor at Scailyte AG. Daniel's ...

Read more

ScaiDigest Volume 7: Unveiling Insights into Autoimmune Diseases

We're thrilled to share the latest installment of our ScaiDigest series, authored by our very own Di...

Read more

Recent News

03 /04

Inside Scailyte – Episode 4: Meet Peter Evans

In this special episode, we introduce you to Peter Evans, our Principal IT Engineer at Scailyte AG. ...

Read more

Inside Scailyte – Episode 3: Meet Peter Nestorov

Join us as Peter Nestorov, the Founder and CEO of Scailyte shares the pivotal role of Scailyte in th...

Read more

Recent News

04 /04

Festival of Genomics 2024

Scailyte will be a part of the upcoming Festival of Genomics, on January 24th and 25th, 2024, in Lon...

Read more

Inside Scailyte - Episode 2: Filipa Teixeira

We're back with another exciting episode of "Inside Scailyte," where we delve into the incredible jo...

Read more

Recent News